{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T17:48:26Z","timestamp":1793209706901,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T00:00:00Z","timestamp":1655769600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.esmoop.2022.100540","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T17:50:28Z","timestamp":1657907428000},"page":"100540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Comparison of actionable events detected in cancer genomes by whole-genome sequencing, in silico whole-exome and mutation panels"],"prefix":"10.1016","volume":"7","author":[{"given":"P.","family":"Ramarao-Milne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Kondrashova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.-M.","family":"Patch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Nones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.T.","family":"Koufariotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Newell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Addala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Lakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Leonard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Mukhopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.","family":"Naeini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Steinfort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Pahoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Twaddell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Grainge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Basirzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Fielding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.","family":"Dalley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Chittoory","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.T.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.G.","family":"Aoude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.F.","family":"Bonazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.P.","family":"Barbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.A.","family":"Fennell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.W.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Creaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Hollway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.V.","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3950-2476","authenticated-orcid":false,"given":"N.","family":"Waddell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7291","key":"10.1016\/j.esmoop.2022.100540_bib1","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nature08987","article-title":"International network of cancer genome projects","volume":"464","author":"Hudson","year":"2010","journal-title":"Nature"},{"issue":"7793","key":"10.1016\/j.esmoop.2022.100540_bib2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","article-title":"Pan-cancer analysis of whole genomes","volume":"578","author":"Campbell","year":"2020","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.esmoop.2022.100540_bib3","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The Cancer Genome Atlas Pan-Cancer analysis project","volume":"45","author":"Weinstein","year":"2013","journal-title":"Nat Genet"},{"issue":"7793","key":"10.1016\/j.esmoop.2022.100540_bib4","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41586-020-1965-x","article-title":"Analyses of non-coding somatic drivers in 2,658 cancer whole genomes","volume":"578","author":"Rheinbay","year":"2020","journal-title":"Nature"},{"issue":"7463","key":"10.1016\/j.esmoop.2022.100540_bib5","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.esmoop.2022.100540_bib6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1470-2045(19)30856-3","article-title":"Larotrectinib in patients with TRK fusion-positive solid tumours: a pooled analysis of three phase 1\/2 clinical trials","volume":"21","author":"Hong","year":"2020","journal-title":"Lancet Oncol"},{"issue":"26","key":"10.1016\/j.esmoop.2022.100540_bib7","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.esmoop.2022.100540_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068824","article-title":"Advantages of single-molecule real-time sequencing in high-GC content genomes","volume":"8","author":"Shin","year":"2013","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.esmoop.2022.100540_bib9","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/bib\/bbu027","article-title":"Exome sequence read depth methods for identifying copy number changes","volume":"16","author":"Kadalayil","year":"2015","journal-title":"Brief Bioinform"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100540_bib10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12859-020-3421-1","article-title":"Comparative study of whole exome sequencing-based copy number variation detection tools","volume":"21","author":"Zhao","year":"2020","journal-title":"BMC Bioinform"},{"issue":"4","key":"10.1016\/j.esmoop.2022.100540_bib11","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ajhg.2012.08.005","article-title":"Discovery and statistical genotyping of copy-number variation from whole-exome sequencing depth","volume":"91","author":"Fromer","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100540_bib12","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1038\/s41467-018-06485-7","article-title":"Clinical cancer genomic profiling by three-platform sequencing of whole genome, whole exome and transcriptome","volume":"9","author":"Rusch","year":"2018","journal-title":"Nat Commun"},{"issue":"17","key":"10.1016\/j.esmoop.2022.100540_bib13","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1073\/pnas.1418631112","article-title":"Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants","volume":"112","author":"Belkadi","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7553","key":"10.1016\/j.esmoop.2022.100540_bib14","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nature14410","article-title":"Whole\u2013genome characterization of chemoresistant ovarian cancer","volume":"521","author":"Patch","year":"2015","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.esmoop.2022.100540_bib15","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/annonc\/mdz132","article-title":"Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers","volume":"30","author":"Nones","year":"2019","journal-title":"Ann Oncol"},{"issue":"7418","key":"10.1016\/j.esmoop.2022.100540_bib16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nature11412","article-title":"Comprehensive molecular portraits of human breast tumours","volume":"490","year":"2012","journal-title":"Nature"},{"issue":"7653","key":"10.1016\/j.esmoop.2022.100540_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nature22071","article-title":"Whole-genome landscapes of major melanoma subtypes","volume":"545","author":"Hayward","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100540_bib18","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1038\/s41467-019-11107-x","article-title":"Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets","volume":"10","author":"Newell","year":"2019","journal-title":"Nat Commun"},{"issue":"7592","key":"10.1016\/j.esmoop.2022.100540_bib19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature16965","article-title":"Genomic analyses identify molecular subtypes of pancreatic cancer","volume":"531","author":"Bailey","year":"2016","journal-title":"Nature"},{"issue":"7540","key":"10.1016\/j.esmoop.2022.100540_bib20","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature14169","article-title":"Whole genomes redefine the mutational landscape of pancreatic cancer","volume":"518","author":"Waddell","year":"2015","journal-title":"Nature"},{"issue":"7643","key":"10.1016\/j.esmoop.2022.100540_bib21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nature21063","article-title":"Whole-genome landscape of pancreatic neuroendocrine tumours","volume":"543","author":"Scarpa","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.esmoop.2022.100540_bib22","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1038\/ncomms6224","article-title":"Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis","volume":"5","author":"Nones","year":"2014","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100540_bib23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13073-022-01060-8","article-title":"Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma","volume":"14","author":"Creaney","year":"2022","journal-title":"Genome Med"},{"key":"10.1016\/j.esmoop.2022.100540_bib24","series-title":"Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM","first-page":"1303","author":"Li","year":"2013"},{"issue":"11","key":"10.1016\/j.esmoop.2022.100540_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074380","article-title":"Somatic point mutation calling in low cellularity tumors","volume":"8","author":"Kassahn","year":"2013","journal-title":"PloS One"},{"issue":"9","key":"10.1016\/j.esmoop.2022.100540_bib26","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res"},{"issue":"2","key":"10.1016\/j.esmoop.2022.100540_bib27","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4161\/fly.19695","article-title":"A\u00a0program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3","volume":"6","author":"Cingolani","year":"2012","journal-title":"Fly (Austin)"},{"key":"10.1016\/j.esmoop.2022.100540_bib28","doi-asserted-by":"crossref","first-page":"15.19.11","DOI":"10.1002\/cpbi.17","article-title":"ascatNgs: identifying somatically acquired copy-number alterations from whole-genome sequencing data","volume":"56","author":"Raine","year":"2016","journal-title":"Curr Protoc Bioinformatics"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100540_bib29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13073-018-0531-8","article-title":"Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations","volume":"10","author":"Tamborero","year":"2018","journal-title":"Genome Med"},{"key":"10.1016\/j.esmoop.2022.100540_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.17.00011","article-title":"OncoKB: a precision oncology knowledge base","volume":"2017","author":"Chakravarty","year":"2017","journal-title":"JCO Precis Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100540_bib63","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","article-title":"The Ensembl Variant Effect Predictor","volume":"17","author":"McLaren","year":"2016","journal-title":"Genome Biol"},{"issue":"7","key":"10.1016\/j.esmoop.2022.100540_bib31","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/bioinformatics\/btt755","article-title":"MSIsensor: microsatellite instability detection using paired tumor-normal sequence data","volume":"30","author":"Niu","year":"2014","journal-title":"Bioinformatics"},{"issue":"2","key":"10.1016\/j.esmoop.2022.100540_bib32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1586\/era.10.226","article-title":"HER2-amplified breast cancer: mechanisms of trastuzumab resistance and novel targeted therapies","volume":"11","author":"Gajria","year":"2011","journal-title":"Expert Rev Anticancer Ther"},{"issue":"2","key":"10.1016\/j.esmoop.2022.100540_bib33","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s10549-017-4419-x","article-title":"Clinical and pathological characterization of HER2 mutations in human breast cancer: a systematic review of the literature","volume":"166","author":"Petrelli","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"36","key":"10.1016\/j.esmoop.2022.100540_bib34","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1200\/JCO.2016.67.5942","article-title":"Phase II study of WEE1 inhibitor AZD1775 plus carboplatin in patients with TP53-mutated ovarian cancer refractory or resistant to first-line therapy within 3 months","volume":"34","author":"Leijen","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.esmoop.2022.100540_bib35","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1158\/2159-8290.CD-18-0804","article-title":"Integrative molecular characterization of malignant pleural mesothelioma","volume":"8","author":"Hmeljak","year":"2018","journal-title":"Cancer Discov"},{"issue":"10272","key":"10.1016\/j.esmoop.2022.100540_bib36","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(20)32714-8","article-title":"First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial","volume":"397","author":"Baas","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100540_bib37","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13073-017-0424-2","article-title":"Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden","volume":"9","author":"Chalmers","year":"2017","journal-title":"Genome Med"},{"issue":"8","key":"10.1016\/j.esmoop.2022.100540_bib38","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/annonc\/mdz116","article-title":"ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1\/PD-L1 expression and tumour mutational burden: a systematic review-based approach","volume":"30","author":"Luchini","year":"2019","journal-title":"Ann Oncol"},{"issue":"7607","key":"10.1016\/j.esmoop.2022.100540_bib39","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/534314a","article-title":"Can you teach old drugs new tricks?","volume":"534","author":"Nosengo","year":"2016","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.esmoop.2022.100540_bib40","doi-asserted-by":"crossref","first-page":"504","DOI":"10.6004\/jnccn.2017.0050","article-title":"Non-small cell lung cancer, version 5.2017, NCCN Clinical Practice Guidelines in Oncology","volume":"15","author":"Ettinger","year":"2017","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"9742","key":"10.1016\/j.esmoop.2022.100540_bib41","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.esmoop.2022.100540_bib42","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/gm482","article-title":"Clinical and molecular characterization of HER2 amplified-pancreatic cancer","volume":"5","author":"Chou","year":"2013","journal-title":"Genome Med"},{"issue":"5","key":"10.1016\/j.esmoop.2022.100540_bib43","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1081\/CNV-200032974","article-title":"Herceptin and gemcitabine for metastatic pancreatic cancers that overexpress HER-2\/neu","volume":"22","author":"Safran","year":"2004","journal-title":"Cancer Invest"},{"issue":"6","key":"10.1016\/j.esmoop.2022.100540_bib44","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/bjc.2012.18","article-title":"Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer","volume":"106","author":"Harder","year":"2012","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.esmoop.2022.100540_bib45","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41588-019-0562-0","article-title":"Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition","volume":"52","author":"Rodriguez-Martin","year":"2020","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100540_bib46","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/s41467-019-13885-w","article-title":"High-coverage whole-genome analysis of 1220 cancers reveals hundreds of genes deregulated by rearrangement-mediated cis-regulatory alterations","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.esmoop.2022.100540_bib47","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1038\/gim.2017.241","article-title":"Clinical whole-genome sequencing from routine formalin-fixed, paraffin-embedded specimens: pilot study for the 100,000 Genomes Project","volume":"20","author":"Robbe","year":"2018","journal-title":"Genet Med"},{"issue":"6","key":"10.1016\/j.esmoop.2022.100540_bib48","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nn.3703","article-title":"Prioritization of neurodevelopmental disease genes by discovery of new mutations","volume":"17","author":"Hoischen","year":"2014","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.esmoop.2022.100540_bib49","article-title":"Achieving reproducibility and accuracy in cancer mutation detection with whole-genome and whole-exome sequencing","year":"2019","journal-title":"bioRxiv"},{"issue":"12","key":"10.1016\/j.esmoop.2022.100540_bib50","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1038\/gim.2018.51","article-title":"Measuring coverage and accuracy of whole-exome sequencing in clinical context","volume":"20","author":"Kong","year":"2018","journal-title":"Genet Med"},{"issue":"3","key":"10.1016\/j.esmoop.2022.100540_bib51","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00439-015-1631-9","article-title":"Clinical sequencing: is WGS the better WES?","volume":"135","author":"Meienberg","year":"2016","journal-title":"Hum Genet"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100540_bib52","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ajhg.2016.12.003","article-title":"Comprehensive rare variant analysis via whole-genome sequencing to determine the molecular pathology of inherited retinal disease","volume":"100","author":"Carss","year":"2017","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100540_bib53","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/s41598-020-59026-y","article-title":"Systematic dissection of biases in whole-exome and whole-genome sequencing reveals major determinants of coding sequence coverage","volume":"10","author":"Barbitoff","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100540_bib54","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/annonc\/mdu479","article-title":"Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data","volume":"26","author":"Favero","year":"2015","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100540_bib55","article-title":"Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project","volume":"8","author":"Merino","year":"2020","journal-title":"J\u00a0Immunother Cancer"},{"issue":"9","key":"10.1016\/j.esmoop.2022.100540_bib56","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/s41591-018-0134-3","article-title":"Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab","volume":"24","author":"Gandara","year":"2018","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.esmoop.2022.100540_bib57","doi-asserted-by":"crossref","first-page":"S321","DOI":"10.1016\/j.jtho.2016.11.343","article-title":"OA20.01 tumor mutation burden (TMB) is associated with improved efficacy of atezolizumab in 1L and 2L+ NSCLC patients","volume":"12","author":"Kowanetz","year":"2017","journal-title":"J\u00a0Thorac Oncol"},{"issue":"6","key":"10.1016\/j.esmoop.2022.100540_bib58","doi-asserted-by":"crossref","first-page":"661","DOI":"10.21037\/tlcr.2018.08.02","article-title":"Methods of measurement for tumor mutational burden in tumor tissue","volume":"7","author":"Mel\u00e9ndez","year":"2018","journal-title":"Transl Lung Cancer Res"},{"issue":"3","key":"10.1016\/j.esmoop.2022.100540_bib59","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s40291-020-00462-x","article-title":"Use of an integrated pan-cancer oncology enrichment next-generation sequencing assay to measure tumour mutational burden and detect clinically actionable variants","volume":"24","author":"Pestinger","year":"2020","journal-title":"Mol Diagn Ther"},{"issue":"4","key":"10.1016\/j.esmoop.2022.100540_bib60","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/ijc.31878","article-title":"Size matters: dissecting key parameters for panel-based tumor mutational burden analysis","volume":"144","author":"Buchhalter","year":"2019","journal-title":"Int J Cancer"},{"issue":"9","key":"10.1016\/j.esmoop.2022.100540_bib61","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1002\/ijc.32002","article-title":"Measurement of tumor mutational burden (TMB) in routine molecular diagnostics: in silico and real-life analysis of three larger gene panels","volume":"144","author":"Endris","year":"2019","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.esmoop.2022.100540_bib62","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2220\/biomedres.39.159","article-title":"Tumor mutational burden analysis of 2,000 Japanese cancer genomes using whole exome and targeted gene panel sequencing","volume":"39","author":"Hatakeyama","year":"2018","journal-title":"Biomed Res"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702922001685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2059702922001685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:27:19Z","timestamp":1761856039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2059702922001685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":63,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S2059702922001685"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2022.100540","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of actionable events detected in cancer genomes by whole-genome sequencing, in silico whole-exome and mutation panels","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2022.100540","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100540"}}